Filing Details

Accession Number:
0001209191-20-020729
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2020-03-23 18:58:16
Reporting Period:
2020-03-18
Accepted Time:
2020-03-23 18:58:16
Original Submission Date:
2020-03-20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1655759 Arvinas Inc. ARVN Pharmaceutical Preparations (2834) 472566120
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1753491 Albert Bradley Margus C/O Arvinas, Inc.
5 Science Park, 395 Winchester Ave.
New Haven CT 06511
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-03-18 40,000 $37.46 59,463 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 42,768 Indirect By Bradley A. Margus Revocable Trust
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.47, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.
  2. This amendment is being filed to clarify that the shares reported on the reporting person's Form 4 filed on March 20, 2020 were sold at a range of transaction prices, and to report the number of shares of Common Stock indirectly held by the reporting person in Table 1.